SCHEMBL311135

SCHEMBL311135

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2ncccc2o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.44
KDM4E B2RXH2 4/20 0.42
HPGD P15428 4/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
POLH Q9Y253 1/20 0.40
PDE4D Q08499 1/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
KMT2A Q03164 1/20 0.38
ABL1 P00519 3/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.37
TOP2A P11388 1/20 0.37
EGFR P00533 1/20 0.36
RET P07949 1/20 0.36
KDR P35968 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312665 0.89 MAOB (0.45) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL312259 0.87 MAOB (0.40) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL312054 0.86 MAOB (0.39) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL311757 0.85 MAOB (0.39) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL312777 0.85 HPGD (0.43) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL312716 0.85 MAOB (0.43) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL313061 0.84 MAOB (0.38) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL312381 0.84 HPGD (0.44) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL324201 0.84 HPGD (0.61) MAOBKDM4EHPGDHSD17B10LMNA
SCHEMBL313600 0.83 MAOB (0.41) MAOBKDM4EHPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed